ANTLER trial shows positive initial data for CB-010 anti-CD19 allogeneic CAR T-cell therapy

Texas federal judge invalidates ACA preventive care mandate—USPSTF, cancer screening, and PrEP in jeopardy

Federal agencies can no longer enforce a critical provision in the Affordable Care Act that requires insurance plans to fully pay for preventive services that receive an “A” or “B” grade from the U.S. Preventive Services Task Force—including many new and updated recommendations on screening for cancer and other diseases.

March 31, 2023

Vol.49 No.13

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Harvard’s Carmel Shachar: Texas ruling that guts ACA preventive care likely to reach Supreme Court—and be upheld

In an era of judicial conservatism, a recent ruling that invalidates the Affordable Care Act’s preventive services mandate is likely to be upheld by higher courts, including the Supreme Court, legal experts say.

March 31, 2023

Vol.49 No.13

By Matthew Bin Han Ong

Conversation with The Cancer Letter

NYU’s Art Caplan: Texas ruling that nixes USPSTF authority embodies “bigotry, hatred, and ignorance”

A ruling by a Texas District Court judge that invalidates the Affordable Care Act’s preventive services mandate is based in part on claims that availability of pre-exposure prophylaxis pills would "encourage homosexual behavior and intravenous drug use.”

March 31, 2023

Vol.49 No.13

By Matthew Bin Han Ong

Conversation with The Cancer Letter Regulatory News

FDA’s Fashoyin-Aje: Draft guidance on accelerated approval urges reliance on randomized controlled trials

FDA last week issued a draft guidance that urges sponsors to conduct randomized controlled trials when they seek accelerated approval.

Rose Kushner: War correspondent and breast cancer advocate

Rose Kushner was a war correspondent during the Vietnam War. She wrote openly about her breast cancer diagnosis in the 1970s, and went on to become an influential breast cancer advocate.

March 31, 2023

Vol.49 No.13

In Brief

Cheryl L. Willman named Stephen and Barbara Slaggie Executive Director of Mayo Clinic Cancer Programs, director of Mayo Clinic Comprehensive Cancer Center

Cheryl L. Willman was named Stephen and Barbara Slaggie Executive Director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehensive Cancer Center following a gift from Stephen M. and Barbara J. Slaggie of Marco Island, FL, and Winona, MN.

March 31, 2023

Vol.49 No.13

ANTLER trial shows positive initial data for CB-010 anti-CD19 allogeneic CAR T-cell therapy

YOU MAY BE INTERESTED IN

Texas federal judge invalidates ACA preventive care mandate—USPSTF, cancer screening, and PrEP in jeopardy

Harvard’s Carmel Shachar: Texas ruling that guts ACA preventive care likely to reach Supreme Court—and be upheld

NYU’s Art Caplan: Texas ruling that nixes USPSTF authority embodies “bigotry, hatred, and ignorance”

FDA’s Fashoyin-Aje: Draft guidance on accelerated approval urges reliance on randomized controlled trials

Rose Kushner: War correspondent and breast cancer advocate

Cheryl L. Willman named Stephen and Barbara Slaggie Executive Director of Mayo Clinic Cancer Programs, director of Mayo Clinic Comprehensive Cancer Center

Renew today!

Subscriber content

Login